VMI
MIST icon

VHCP Management II’s Milestone Pharmaceuticals MIST Stock Holding History

VHCP Management II’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2.38M Hold
148,560
– – 0.63% 15
2019
Q3 		$2.77M Hold
148,560
– – 1.06% 16
2019
Q2 		$4.03M Buy
+148,560
New +$3.06M 1.27% 16

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VHCP Management II's MIST Position: Q4 2019 in Review

VHCP Management II held its Milestone Pharmaceuticals (MIST) position steady in Q4 2019 at 148,560 shares worth $2.38M. The position accounts for 0.63% of the portfolio, ranked #15.

VHCP Management II first reported a position in MIST in Q2 2019 and has held it in 3 quarters since. The position peaked at $4.03M in Q2 2019. 25 funds tracked by Wall St. Rank hold MIST as of Q4 2019.

  • VHCP Management II held 148,560 shares of Milestone Pharmaceuticals worth $2.38M as of Q4 2019.
  • VHCP Management II left its Milestone Pharmaceuticals share count unchanged in Q4 2019.
  • Milestone Pharmaceuticals made up 0.63% of VHCP Management II's portfolio in Q4 2019, its #15 holding.
  • VHCP Management II first reported a position in Milestone Pharmaceuticals in Q2 2019 and has held it in 3 quarters since.
  • VHCP Management II's Milestone Pharmaceuticals position peaked at $4.03M in Q2 2019.
  • 25 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q4 2019.

Based on VHCP Management II's 13F filing for Q4 2019, filed 13 Feb 2020.